As healthcare challenges continue to grow, so does the need for innovative ways to meet them. Observe Medical develops medtech solutions that help ensure healthcare professionals and patients benefit from the highest standards of care safely and cost-effectively.
Oslo June 30, 2021 – Observe Medical ASA (OSE: OBSRV), today announces that it has entered into a distribution agreement and partnership with Skamex (Poland) for the launch of Sippi® in the Polish and the Romanian market. “We are pleased to announce that we are taking additional steps in the roll-out of Sippi® through our…
Read moreObserve Medical ASA has today, May 21, 2021, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. Björn Larsson, CEO, Observe Medical ASA Tel.: + 46 76 620 17…
Read moreOslo, 20 May 2021: In connection with the annual general meeting of Observe Medical ASA (the "Company") to be held on 21 May 2021 (the "AGM"), Terje Bakken, chairman of the board of directors of the Company, has as at the close of trading on the Oslo Stock Exchange on 20 May 2021, received proxies…
Read moreObserve Medical is a Nordic based medtech developer with development, quality, regulatory and commercial operations in Gothenburg, Sweden, and headquarters in Oslo, Norway.
The prevalence and cost of hospital acquired infection are growing challenges for healthcare facilities. Sippi infection inhibiting automated digital urine meter system from Observe Medical can help.